A Randomized, Open-Label, Two-Way Crossover, Single-Dose Bioequivalence Study of Temozolomide 200 mg/m2 (Dralitem® vs. Temodal® Capsules) in Patients with Primary Tumors of the Central Nervous System Under Fasting Conditions
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-6901
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
A Randomized, Open-Label, Two-Way Crossover, Single-Dose Bioequivalence Study of Temozolomide 200 mg/m2 (Dralitem® vs. Temodal® Capsules) in Patients with Primary Tumors of the Central Nervous System Under Fasting Conditions ; volume:17 ; number:3 ; day:29 ; month:7 ; year:2017 ; pages:427-434 ; date:9.2017
Drugs in R & D ; 17, Heft 3 (29.7.2017), 427-434, 9.2017
- Keyword
-
Krebs
Onkologie
- Creator
-
Muggeri, Alejandro
- Contributor
-
Vago, Miguel
Pérez, Sebastián
Rubio, Marcelo
González, Cecilia
Magariños, Cristian
Rosenberg, Mónica
Costa, Fernando
Perez-Lloret, Santiago
SpringerLink (Online service)
- DOI
-
10.1007/s40268-017-0199-3
- URN
-
urn:nbn:de:1111-201711295570
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Muggeri, Alejandro
- Vago, Miguel
- Pérez, Sebastián
- Rubio, Marcelo
- González, Cecilia
- Magariños, Cristian
- Rosenberg, Mónica
- Costa, Fernando
- Perez-Lloret, Santiago
- SpringerLink (Online service)